Top Markets
Coin of the day
Organicell Regenerative Medicine, Inc. Organicell Regenerative Medicine, Inc.

Organicell Regenerative Medicine, Inc.

OCEL
株式のランク #31539
Organicell Regenerative Medicine, Inc. is a clinical-stage biopharmaceutical... Organicell Regenerative Medicine, Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering biological therapies for degenerative conditions. Their primary investigational product is Zofin, an acellular biological treatment sourced from perinatal material. This therapeutic is specifically processed to preserve its inherent microRNAs, without the inclusion of any artificial additives or diluents. Zofin is currently undergoing Phase I/II clinical evaluation for its efficacy against COVID-19. Beyond its core drug development, Organicell also offers independent educational, promotional, and marketing solutions to various healthcare sectors, including medical, anti-aging, and regenerative service providers. The company maintains key research collaborations: one with the Centers for Disease Control and Prevention (CDC) to explore Zofin's anti-inflammatory and anti-infective capabilities in experimental influenza models, and another with Oklahoma State University to assess Zofin's potential in treating severe respiratory illnesses stemming from viruses with pandemic risk. Founded in 2011, this Miami, Florida-based company initially operated as Biotech Products Services and Research, Inc. It adopted its current name, Organicell Regenerative Medicine, Inc., in June 2018.
株価
$1.77
最終同期: 2024-04-02
時価総額
$12.89M
変化(1日)
-11.50%
変化(1年)
0.00%
US
取引 Organicell Regenerative Medicine, Inc. (OCEL)

カテゴリー

Organicell Regenerative Medicine, Inc.(OCEL)の株価履歴
終値の最高値: $1.89 (2024-04-01)

終値の最安値: $117.90 (2016-03-01)
Organicell Regenerative Medicine, Inc. の株価履歴(2016 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2024 42.05%
2023 -70.50%
2022 -42.43%
2021 -72.54%
2020 504.63%
2019 263.71%
2018 -40.90%
2017 -91.64%
2016 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$515.58 32.24%
US
$992.01 50.00%
NL
$111.31 -36.83%
AU
$734.30 6.65%
CH
$1.06K -7.04%
KR